4//SEC Filing
Saad Kareem 4
Accession 0001415889-24-007681
CIK 0001818331other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:25 PM ET
Size
7.4 KB
Accession
0001415889-24-007681
Insider Transaction Report
Form 4
Saad Kareem
Chief Business Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2024-03-09+2,841→ 27,308 total - Exercise/Conversion
Restricted Stock Unit
2024-03-09−2,841→ 31,249 total→ Class A Common Stock (2,841 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001873805
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 5:25 PM ET
- Size
- 7.4 KB